JORGE CASTILLO to Everolimus
This is a "connection" page, showing publications JORGE CASTILLO has written about Everolimus.
Connection Strength
0.250
-
Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214). Clin Cancer Res. 2017 May 15; 23(10):2400-2404.
Score: 0.133
-
Biology, prognosis, and therapy of Waldenstr?m Macroglobulinemia. Cancer Treat Res. 2015; 165:177-95.
Score: 0.117